A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib
NCT04253223
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
poor accrual
Conditions
Hyperglycemia Drug Induced
Interventions
BIOLOGICAL:
REMD-477
Sponsor
Duke University